Towards an optimal TRIPS-compliant industrial policy for the pharmaceutical industry in Bangladesh

dc.contributor.authorAla, M.U.
dc.contributor.conferencePublic Policy in the 'Asian Century' conference (9 Dec 2012 - 10 Dec 2012 : Melbourne, Australia)
dc.contributor.editorSullivan, H.
dc.date.issued2013
dc.description.abstractSince 1982, under a protective regulatory regime, Bangladesh has attained self-sufficiency in off-patent drugs. Of significance, all LDCs including Bangladesh need to implement the Agreement on Trade Related Intellectual Property Rights (TRIPS) of the WTO in 2016. Thisregulatory change warrantsenhanced technology and R&D adoption to improve firms’ competitiveness. Using data obtained from 94 pharmaceutical companies through a questionnaire survey, this study provides an empirical analysis of firm-level TRIPS-related vulnerability facing the Bangladeshi pharmaceutical sector. Ifind that R&D-related and international competitiveness-related vulnerabilities are the most important types of vulnerability. A vulnerability-based classification using cluster analysis reveals that the least vulnerable firms have comparatively higher involvement in independentand collaborative R&D activities.However, at the industry level, the inter-firm and firm-academia/institution collaboration is significantly low. Thestudy underlines the importance of careful policy intervention to providesustained institutional support to create incentives for multidimensional R&D collaboration,including public-private partnerships.
dc.identifier.citationPublic Policy in the 'Asian Century' conference, 2013 / Sullivan, H. (ed./s)
dc.identifier.urihttps://hdl.handle.net/1959.8/154955
dc.language.isoen
dc.publisherUniversity of Melbourne
dc.publisher.placeAustralia
dc.rightsCopyright 2013 The Author
dc.source.urihttp://bespoke-production.s3.amazonaws.com/msog/assets/3a/e70e80b85911e696aac9ce2d0cb16b/MSoG_2013_Conference_Paper_Mamun_Ul_Ala.pdf
dc.subjectpharmaceutical industr
dc.subjectBangladesh
dc.subjectpublic policy
dc.titleTowards an optimal TRIPS-compliant industrial policy for the pharmaceutical industry in Bangladesh
dc.typeConference paper
pubs.publication-statusPublished
ror.fileinfo12150459670001831 13150469640001831 MSoG_2013_Conference_Paper_Mamun_Ul_Ala.pdf
ror.mmsid9915909638701831

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
9915909638701831_12150459670001831_MSoG_2013_Conference_Paper_Mamun_Ul_Ala.pdf
Size:
681.16 KB
Format:
Adobe Portable Document Format
Description:
Published version

Collections